4//SEC Filing
Brewer Joanna Elizabeth 4
Accession 0001104659-22-056007
CIK 0001621227other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 9:03 PM ET
Size
8.5 KB
Accession
0001104659-22-056007
Insider Transaction Report
Form 4
Brewer Joanna Elizabeth
Chief Scientific Officer
Transactions
- Award
Option to purchase Ordinary Shares
2022-05-04+333,792→ 333,792 totalExercise: $0.30Exp: 2032-05-04→ Ordinary Shares (333,792 underlying) - Award
Option to purchase Ordinary Shares
2022-05-04+223,512→ 223,512 totalExercise: $0.00Exp: 2032-05-04→ Ordinary Shares (223,512 underlying)
Footnotes (4)
- [F1]The exercise price was converted from GBP0.24 based on an exchange rate of U.S.$1.2513 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F2]Exercisable as to 83,448 Ordinary Shares on May 4, 2023 and will be exercisable as to the remainder in monthly installments of 6,954 Ordinary Shares on the fourth of each month from June 4, 2023 through May 4, 2026.
- [F3]The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$1.2513 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F4]Exercisable as to 55,878 Ordinary Shares on May 4, 2023 and will be exercisable as to the remainder in annual installments of 55,878 Ordinary Shares on the fourth of each May from May 4, 2024 through May 4, 2026.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001923834
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 9:03 PM ET
- Size
- 8.5 KB